While lower price cards might help alleviate the load of large drug fees while in the temporary, they do not handle the systemic challenges driving up prescription costs within the U.S. Broader coverage variations could tackle the basis brings about of increasing drug prices, which include deficiency of transparency in pricing and the role of inter